OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2022
(3)
2021
(2)
2023
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years.
Not available
S-EPMC7383505
|
biostudies-literature
Cite
Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.
Not available
S-EPMC9826472
|
biostudies-literature
Cite
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.
Not available
S-EPMC9804523
|
biostudies-literature
Cite
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation.
Not available
S-EPMC8961219
|
biostudies-literature
Cite
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.
Not available
S-EPMC8405981
|
biostudies-literature
Cite
AFP score and metroticket 2.0 perform similarly and could be used in a "within-ALL" clinical decision tool.
Not available
S-EPMC9860475
|
biostudies-literature
Cite
Neurologic manifestations associated with COVID-19: a multicentre registry.
Not available
S-EPMC7661948
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets